Evogene EVGN
NASDAQ EVGN
$0.56 +0.00 (+0.36%)
At close: Aug 21, 2026 · 4:00 PM EDT

Evogene (EVGN) FCF Payout Ratio Growth (1y) (2021 - 2026)

Evogene (EVGN) FCF Payout Ratio Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 68.88%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -31.89%
10 Evogene 4.38 Mn 4.38 Mn 204,000.00 -94.68%

Historic Data

Download Data
DateValue
Mar 31, 2026 -94.68%
Jun 30, 2021 83.00%
Mar 31, 2021 -38.91%